CDTX vs DD
Cidara Therapeutics Inc (CDTX) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
CDTX currently screens at market cap $6.96B. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the CDTX and DD stock pages for the full models.
Not investment advice.